Arka Chatterjee, MD
Interventional Cardiology · Birmingham, ALNPI 1578890992
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Edwards Lifesciences at 52.0% of the total.
Across 182 payments — averaging $90.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$9K
- Abbott$3K
- Angiodynamics, Inc.$1K
- Medtronic$969
- Abiomed$568
- Shockwave Medical, Inc$436
- plus $2K from 12 others
Across 5 payments — averaging $2315.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cardiovascular Systems Inc.$12K
- Abiomed$50
What the payments were for
- Consulting fees$2,50015%
- Travel & lodging$4,71229%
- Food & beverage$9,24956%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 75 | $8,567 |
| Abbott | 31 | $3,132 |
| Angiodynamics, Inc. | 4 | $1,134 |
| Medtronic | 14 | $969 |
| Abiomed | 5 | $568 |
| Shockwave Medical, Inc | 20 | $436 |
| Boston Scientific | 10 | $276 |
| Cardiac Dimensions, Inc. | 3 | $241 |
| Philips North America LLC | 5 | $192 |
| W. L. Gore & Associates, Inc. | 2 | $176 |
| Penumbra, Inc. | 2 | $163 |
| Teleflex LLC | 1 | $145 |
| Inari Medical, Inc. | 1 | $137 |
| Terumo Medical Corporation | 3 | $127 |
| Cvrx, Inc. | 1 | $98 |
| Biosense Webster, Inc. | 2 | $70 |
| Cardiva Medical, Inc. | 1 | $22 |
| Cardiovascular Systems Inc. | 2 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SAPIEN 3 Ultra RESILIA$2,599
- Edwards SAPIEN 3 Transcatheter Heart Valve$2,160
- PASCAL$1,649
- MitraClip$1,016
- AMPLATZER$867
- TRICLIP$762
- COREVALVE EVOLUT R$500
- Impella$371
- CARDIOFORM Septal Occluder$147
- GUIDELINER$145
- Indigo System$139
- FLOWTRIEVER CATHETER, S$137
- CT THROMBECTOMY SYSTEM KIT$137
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$119
- MITRIS RESILIA Mitral Valve$110
- ONYX FRONTIER$101
- INSPIRIS RESILIA aortic valve$100
How this compares
$16,461 in reported general payments places this provider in the 75th percentile of 109 interventional cardiology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 28 | $44,332 |
| EntrestoSacubitril/Valsartan | 14 | $16,784 |
| XareltoRivaroxaban | 12 | $15,308 |
| Ranolazine ErRanolazine | 14 | $2,355 |
| Metoprolol Succinate | 99 | $1,633 |
| Rosuvastatin Calcium | 89 | $1,337 |
| ClopidogrelClopidogrel Bisulfate | 81 | $1,202 |
| Nitroglycerin PatchNitroglycerin | 20 | $896 |
| Ezetimibe | 23 | $685 |
| Telmisartan | 17 | $528 |
| Losartan Potassium | 32 | $440 |
| Atorvastatin Calcium | 67 | $431 |
| Carvedilol | 61 | $375 |
| Furosemide | 66 | $357 |
| Nitroglycerin | 19 | $310 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Birmingham
- Gary RoubinBirmingham$157K
- Robert FosterBirmingham$90K
- Hasan GuvenBirmingham$86K
- Abdullah MahmoodBirmingham$61K
- Ali EbrahimiBirmingham$55K
- Jacob TownsendBirmingham$52K
- Kamran AliBirmingham$47K
- Mouhamed SabouniBirmingham$44K
- David SchultzBirmingham$19K
- Tushar MishraBirmingham$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.